{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:35:21Z","timestamp":1790516121967,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The development of bronchial hyperreactivity (BHR) subsequent to precapillary pulmonary hypertension (PHT) was prevented by acting on the major signalling pathways (endothelin, nitric oxide, vasoactive intestine peptide (VIP) and prostacyclin) involved in the control of the pulmonary vascular and bronchial tones.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Five groups of rats underwent surgery to prepare an aorta-caval shunt (ACS) to induce sustained precapillary PHT for 4 weeks. During this period, no treatment was applied in one group (ACS controls), while the other groups were pretreated with VIP, iloprost, tezosentan via an intraperitoneally implemented osmotic pump, or by orally administered sildenafil. An additional group underwent sham surgery. Four weeks later, the lung responsiveness to increasing doses of an intravenous infusion of methacholine (2, 4, 8 12 and 24 \u03bcg\/kg\/min) was determined by using the forced oscillation technique to assess the airway resistance (Raw).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>BHR developed in the untreated rats, as reflected by a significant decrease in ED<jats:sub>50<\/jats:sub>, the equivalent dose of methacholine required to cause a 50% increase in Raw. All drugs tested prevented the development of BHR, iloprost being the most effective in reducing both the systolic pulmonary arterial pressure (Ppa; 28%, p = 0.035) and BHR (ED<jats:sub>50<\/jats:sub>= 9.9 \u00b1 1.7 vs. 43 \u00b1 11 \u03bcg\/kg in ACS control and iloprost-treated rats, respectively, p = 0.008). Significant correlations were found between the levels of Ppa and ED<jats:sub>50<\/jats:sub>(R = -0.59, p = 0.016), indicating that mechanical interdependence is primarily responsible for the development of BHR.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The efficiency of such treatment demonstrates that re-establishment of the balance of constrictor\/dilator mediators via various signalling pathways involved in PHT is of potential benefit for the avoidance of the development of BHR.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1465-9921-12-58","type":"journal-article","created":{"date-parts":[[2011,4,27]],"date-time":"2011-04-27T18:35:49Z","timestamp":1303929349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prevention of bronchial hyperreactivity in a rat model of precapillary pulmonary hypertension"],"prefix":"10.1186","volume":"12","author":[{"given":"Walid","family":"Habre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely","family":"Albu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor Z","family":"Janosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Fontao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta S","family":"von Ungern-Sternberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Beghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc","family":"Petak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,1]]},"reference":[{"key":"1078_CR1","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1164\/rccm.2512003","volume":"173","author":"MM Hoeper","year":"2006","unstructured":"Hoeper MM, Rubin LJ: Update in pulmonary hypertension 2005. Am J Respir Crit Care Med. 2006, 173: 499-505. 10.1164\/rccm.2512003.","journal-title":"Am J Respir Crit Care Med"},{"key":"1078_CR2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1056\/NEJM199801293380501","volume":"338","author":"VV McLaughlin","year":"1998","unstructured":"McLaughlin VV, Genthner DE, Panella MM, Rich S: Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med. 1998, 338: 273-277. 10.1056\/NEJM199801293380501.","journal-title":"N Engl J Med"},{"key":"1078_CR3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/01.ccx.0000224867.78581.0c","volume":"12","author":"S Murali","year":"2006","unstructured":"Murali S: Pulmonary arterial hypertension. Curr Opin Crit Care. 2006, 12: 228-234. 10.1097\/01.ccx.0000224867.78581.0c.","journal-title":"Curr Opin Crit Care"},{"key":"1078_CR4","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1378\/chest.130.4.1198","volume":"130","author":"S Rich","year":"2006","unstructured":"Rich S: The current treatment of pulmonary arterial hypertension: time to redefine success. Chest. 2006, 130: 1198-1202. 10.1378\/chest.130.4.1198.","journal-title":"Chest"},{"key":"1078_CR5","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/NEJMra040291","volume":"351","author":"M Humbert","year":"2004","unstructured":"Humbert M, Sitbon O, Simonneau G: Treatment of pulmonary arterial hypertension. N Engl J Med. 2004, 351: 1425-1436. 10.1056\/NEJMra040291.","journal-title":"N Engl J Med"},{"key":"1078_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.prrv.2005.09.006","volume":"6","author":"LS Howard","year":"2005","unstructured":"Howard LS, Morrell NW: New therapeutic agents for pulmonary vascular disease. Paediatr Respir Rev. 2005, 6: 285-291. 10.1016\/j.prrv.2005.09.006.","journal-title":"Paediatr Respir Rev"},{"key":"1078_CR7","doi-asserted-by":"crossref","first-page":"519","DOI":"10.33549\/physiolres.930000.49.519","volume":"49","author":"IM Keith","year":"2000","unstructured":"Keith IM: The role of endogenous lung neuropeptides in regulation of the pulmonary circulation. Physiol Res. 2000, 49: 519-537.","journal-title":"Physiol Res"},{"key":"1078_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1465-9921-7-45","volume":"7","author":"W Habre","year":"2006","unstructured":"Habre W, Petak F, Ruchonnet-Metrailler I, Donati Y, Tolsa JF, Lele E, Albu G, Beghetti M, Barazzone-Argiroffo C: The role of endothelin-1 in hyperoxia-induced lung injury in mice. Respir Res. 2006, 7: 45-10.1186\/1465-9921-7-45.","journal-title":"Respir Res"},{"key":"1078_CR9","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nrd2030","volume":"5","author":"HA Ghofrani","year":"2006","unstructured":"Ghofrani HA, Osterloh IH, Grimminger F: Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. Nat Rev Drug Discov. 2006, 5: 689-702. 10.1038\/nrd2030.","journal-title":"Nat Rev Drug Discov"},{"key":"1078_CR10","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1113\/expphysiol.2008.042481","volume":"93","author":"T Janosi","year":"2008","unstructured":"Janosi T, Petak F, Fontao F, Morel DR, Beghetti M, Habre W: Differential roles of endothelin-1 ETA and ETB receptors and vasoactive intestinal polypeptide in regulation of the airways and the pulmonary vasculature in isolated rat lung. Exp Physiol. 2008, 93: 1210-1219. 10.1113\/expphysiol.2008.042481.","journal-title":"Exp Physiol"},{"key":"1078_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3109\/01902140903214667","volume":"36","author":"BS von Ungern-Sternberg","year":"2010","unstructured":"von Ungern-Sternberg BS, Habre W, Regli A, Pache JC, Fontao F, Janosi TZ, Beghetti M, Petak F: Precapillary pulmonary hypertension leads to reversible bronchial hyperreactivity in rats. Exp Lung Res. 2010, 36: 129-139. 10.3109\/01902140903214667.","journal-title":"Exp Lung Res"},{"key":"1078_CR12","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1093\/cvr\/24.5.430","volume":"24","author":"R Garcia","year":"1990","unstructured":"Garcia R, Diebold S: Simple, rapid, and effective method of producing aortocaval shunts in the rat. Cardiovasc Res. 1990, 24: 430-432. 10.1093\/cvr\/24.5.430.","journal-title":"Cardiovasc Res"},{"key":"1078_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1023\/A:1025450403668","volume":"251","author":"C Ocampo","year":"2003","unstructured":"Ocampo C, Ingram P, Ilbawi M, Arcilla R, Gupta M: Revisiting the surgical creation of volume load by aorto-caval shunt in rats. Mol Cell Biochem. 2003, 251: 139-143. 10.1023\/A:1025450403668.","journal-title":"Mol Cell Biochem"},{"key":"1078_CR14","doi-asserted-by":"publisher","first-page":"L607","DOI":"10.1152\/ajplung.00222.2009","volume":"298","author":"W Habre","year":"2010","unstructured":"Habre W, Janosi TZ, Fontao F, Meyers C, Albu G, Pache JC, Petak F: Mechanisms for lung function impairment and airway hyperresponsiveness following chronic hypoxia in rats. Am J Physiol Lung Cell Mol Physiol. 2010, 298: L607-614. 10.1152\/ajplung.00222.2009.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1078_CR15","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1152\/japplphysiol.00011.2006","volume":"101","author":"TZ Janosi","year":"2006","unstructured":"Janosi TZ, Adamicza A, Zosky GR, Asztalos T, Sly PD, Hantos Z: Plethysmographic estimation of thoracic gas volume in apneic mice. J Appl Physiol. 2006, 101: 454-459. 10.1152\/japplphysiol.00011.2006.","journal-title":"J Appl Physiol"},{"key":"1078_CR16","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1063\/1.365927","volume":"82","author":"F Petak","year":"1997","unstructured":"Petak F, Hantos Z, Adamicza A, Asztalos T, Sly PD: Methacholine-induced bronchoconstriction in rats: effects of intravenous vs. aerosol delivery. J Appl Physiol. 1997, 82: 1479-1487. 10.1063\/1.365927.","journal-title":"J Appl Physiol"},{"key":"1078_CR17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1152\/jappl.2002.92.1.169","volume":"92","author":"F Petak","year":"2002","unstructured":"Petak F, Habre W, Hantos Z, Sly PD, Morel DR: Effects of pulmonary vascular pressures and flow on airway and parenchymal mechanics in isolated rat lungs. J Appl Physiol. 2002, 92: 169-178.","journal-title":"J Appl Physiol"},{"key":"1078_CR18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1063\/1.352153","volume":"72","author":"Z Hantos","year":"1992","unstructured":"Hantos Z, Daroczy B, Suki B, Nagy S, Fredberg JJ: Input impedance and peripheral inhomogeneity of dog lungs. J Appl Physiol. 1992, 72: 168-178. 10.1063\/1.352153.","journal-title":"J Appl Physiol"},{"key":"1078_CR19","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1063\/1.368257","volume":"84","author":"F Petak","year":"1998","unstructured":"Petak F, Hall GL, Sly PD: Repeated measurements of airway and parenchymal mechanics in rats by using low-frequency oscillations. J Appl Physiol. 1998, 84: 1680-1686. 10.1063\/1.368257.","journal-title":"J Appl Physiol"},{"key":"1078_CR20","doi-asserted-by":"publisher","first-page":"H2334","DOI":"10.1152\/ajpheart.00375.2005","volume":"289","author":"CF Lam","year":"2005","unstructured":"Lam CF, Peterson TE, Croatt AJ, Nath KA, Katusic ZS: Functional adaptation and remodeling of pulmonary artery in flow-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol. 2005, 289: H2334-2341. 10.1152\/ajpheart.00375.2005.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1078_CR21","doi-asserted-by":"publisher","first-page":"L239","DOI":"10.1152\/ajplung.00413.2006","volume":"293","author":"GL Larsen","year":"2007","unstructured":"Larsen GL, Loader J, Fratelli C, Kang JK, Dakhama A, Colasurdo GN: Modulation of airway responses by prostaglandins in young and fully grown rabbits. Am J Physiol Lung Cell Mol Physiol. 2007, 293: L239-244. 10.1152\/ajplung.00413.2006.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1078_CR22","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1152\/physrev.00034.2003","volume":"84","author":"FL Ricciardolo","year":"2004","unstructured":"Ricciardolo FL, Sterk PJ, Gaston B, Folkerts G: Nitric oxide in health and disease of the respiratory system. Physiol Rev. 2004, 84: 731-765. 10.1152\/physrev.00034.2003.","journal-title":"Physiol Rev"},{"key":"1078_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1136\/hrt.79.2.175","volume":"79","author":"TW Higenbottam","year":"1998","unstructured":"Higenbottam TW, Butt AY, Dinh-Xaun AT, Takao M, Cremona G, Akamine S: Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost. Heart. 1998, 79: 175-179.","journal-title":"Heart"},{"key":"1078_CR24","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1183\/09031936.00097107","volume":"31","author":"M Gomberg-Maitland","year":"2008","unstructured":"Gomberg-Maitland M, Olschewski H: Prostacyclin therapies for the treatment of pulmonary arterial hypertension. Eur Respir J. 2008, 31: 891-901. 10.1183\/09031936.00097107.","journal-title":"Eur Respir J"},{"key":"1078_CR25","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","volume":"328","author":"A Giaid","year":"1993","unstructured":"Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ: Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med. 1993, 328: 1732-1739. 10.1056\/NEJM199306173282402.","journal-title":"N Engl J Med"},{"key":"1078_CR26","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1056\/NEJMoa050010","volume":"353","author":"N Galie","year":"2005","unstructured":"Galie N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, et al: Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med. 2005, 353: 2148-2157. 10.1056\/NEJMoa050010.","journal-title":"N Engl J Med"},{"key":"1078_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1164\/ajrccm.150.1.8025755","volume":"150","author":"RH Brown","year":"1994","unstructured":"Brown RH, Zerhouni EA, Hirshman CA: Reversal of bronchoconstriction by inhaled nitric oxide. Histamine versus methacholine. Am J Respir Crit Care Med. 1994, 150: 233-237.","journal-title":"Am J Respir Crit Care Med"},{"key":"1078_CR28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1183\/09031936.93.06020177","volume":"6","author":"M Hogman","year":"1993","unstructured":"Hogman M, Frostell C, Arnberg H, Hedenstierna G: Inhalation of nitric oxide modulates methacholine-induced bronchoconstriction in the rabbit. Eur Respir J. 1993, 6: 177-180.","journal-title":"Eur Respir J"},{"key":"1078_CR29","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1097\/00005344-199405000-00022","volume":"23","author":"MR MacLean","year":"1994","unstructured":"MacLean MR, McCulloch KM, Baird M: Endothelin ETA- and ETB-receptor-mediated vasoconstriction in rat pulmonary arteries and arterioles. J Cardiovasc Pharmacol. 1994, 23: 838-845. 10.1097\/00005344-199405000-00022.","journal-title":"J Cardiovasc Pharmacol"},{"key":"1078_CR30","doi-asserted-by":"publisher","first-page":"L772","DOI":"10.1152\/ajplung.00405.2007","volume":"294","author":"HH Leuchte","year":"2008","unstructured":"Leuchte HH, Meis T, El-Nounou M, Michalek J, Behr J: Inhalation of endothelin receptor blockers in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2008, 294: L772-777. 10.1152\/ajplung.00405.2007.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1078_CR31","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1093\/eurheartj\/ehn234","volume":"29","author":"CF Opitz","year":"2008","unstructured":"Opitz CF, Ewert R, Kirch W, Pittrow D: Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?. Eur Heart J. 2008, 29: 1936-1948. 10.1093\/eurheartj\/ehn234.","journal-title":"Eur Heart J"},{"key":"1078_CR32","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.regpep.2006.10.012","volume":"139","author":"S Anaid","year":"2007","unstructured":"Anaid S, Petkov V, Baykuscheva-Gentscheva T, Hoeger H, Painsipp E, Holzer P, Mosgoeller W: Involvement of endothelial NO in the dilator effect of VIP on rat isolated pulmonary artery. Regul Pept. 2007, 139: 102-108. 10.1016\/j.regpep.2006.10.012.","journal-title":"Regul Pept"},{"key":"1078_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1159\/000196643","volume":"64","author":"S Iwabuchi","year":"1997","unstructured":"Iwabuchi S, Ono S, Tanita T, Koike K, Fujimura S: Vasoactive intestinal peptide causes nitric oxide-dependent pulmonary vasodilation in isolated rat lung. Respiration. 1997, 64: 54-58. 10.1159\/000196643.","journal-title":"Respiration"},{"key":"1078_CR34","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/0091-6749(88)90973-6","volume":"82","author":"N Crimi","year":"1988","unstructured":"Crimi N, Palermo F, Oliveri R, Palermo B, Vancheri C, Polosa R, Mistretta A: Effect of vasoactive intestinal peptide (VIP) on propranolol-induced bronchoconstriction. J Allergy Clin Immunol. 1988, 82: 617-621. 10.1016\/0091-6749(88)90973-6.","journal-title":"J Allergy Clin Immunol"},{"key":"1078_CR35","doi-asserted-by":"publisher","first-page":"C375","DOI":"10.1152\/ajpcell.00495.2005","volume":"291","author":"BM Hagen","year":"2006","unstructured":"Hagen BM, Bayguinov O, Sanders KM: VIP and PACAP regulate localized Ca2+ transients via cAMP-dependent mechanism. Am J Physiol Cell Physiol. 2006, 291: C375-385. 10.1152\/ajpcell.00495.2005.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1078_CR36","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1476-5381.1996.tb15719.x","volume":"119","author":"M Kishi","year":"1996","unstructured":"Kishi M, Takeuchi T, Suthamnatpong N, Ishii T, Nishio H, Hata F, Takewaki T: VIP- and PACAP-mediated nonadrenergic, noncholinergic inhibition in longitudinal muscle of rat distal colon: involvement of activation of charybdotoxin- and apamin-sensitive K+ channels. Br J Pharmacol. 1996, 119: 623-630.","journal-title":"Br J Pharmacol"},{"key":"1078_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/BF02255914","volume":"7","author":"TJ Lee","year":"2000","unstructured":"Lee TJ: Nitric oxide and the cerebral vascular function. J Biomed Sci. 2000, 7: 16-26. 10.1007\/BF02255914.","journal-title":"J Biomed Sci"},{"key":"1078_CR38","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI17500","volume":"111","author":"V Petkov","year":"2003","unstructured":"Petkov V, Mosgoeller W, Ziesche R, Raderer M, Stiebellehner L, Vonbank K, Funk GC, Hamilton G, Novotny C, Burian B, Block LH: Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension. J Clin Invest. 2003, 111: 1339-1346.","journal-title":"J Clin Invest"},{"key":"1078_CR39","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1183\/09031936.00050008","volume":"32","author":"HH Leuchte","year":"2008","unstructured":"Leuchte HH, Baezner C, Baumgartner RA, Bevec D, Bacher G, Neurohr C, Behr J: Inhalation of vasoactive intestinal peptide in pulmonary hypertension. Eur Respir J. 2008, 32: 1289-1294. 10.1183\/09031936.00050008.","journal-title":"Eur Respir J"},{"key":"1078_CR40","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1164\/arrd.1984.130.2.162","volume":"130","author":"PJ Barnes","year":"1984","unstructured":"Barnes PJ, Dixon CM: The effect of inhaled vasoactive intestinal peptide on bronchial reactivity to histamine in humans. Am Rev Respir Dis. 1984, 130: 162-166.","journal-title":"Am Rev Respir Dis"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-12-58.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1465-9921-12-58\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-12-58.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T08:39:02Z","timestamp":1741163942000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/1465-9921-12-58"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1078"],"URL":"https:\/\/doi.org\/10.1186\/1465-9921-12-58","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"7 December 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"58"}}